HB 1335 Florida House · 2025 Regular Session

Biomarker Testing

Summary

Biomarker Testing; Requires AHCA to establish provider reimbursement schedule & billing codes for specified medical services & procedures coding to cover biomarker testing; authorizes Medicaid program coverage of certain colorectal cancer tests; requires Medicaid managed care plans to cover certain colorectal cancer tests at certain level; requires agency to contract for cost-benefit analysis.

Issues: ✓ Healthcare

Bill status died 3 of 5 stages cleared

Introduction

Feb 2025

Committee Review

Apr 2025

House Passage

Apr 2025

Senate Passage

Governor

Introduced Feb 27, 2025 Last action Jun 16, 2025

Maddy AI version diff · 1 comparison

What changed between versions

H 1335 Filed → H 1335 c1 · 6 edits

MODERATE

The bill was completely rewritten from a focus on colorectal cancer screening coverage to establishing biomarker testing services within Florida's Medicaid program. The original version required health insurers to cover colorectal cancer screenings without cost-sharing, while the new version defines biomarker testing, establishes reimbursement schedules, and authorizes Medicaid coverage for specific colorectal cancer tests.

Scope change

The bill's scope shifted from covering colorectal cancer screening for multiple types of health insurance plans (individual, group, HMO) to specifically establishing biomarker testing services and colorectal cancer test coverage within Florida's Medicaid program.

SCOPE

Bill title and purpose changed from colorectal cancer screening coverage to biomarker testing services and Medicaid coverage of colorectal cancer tests.

DEFINITION

New definitions added for 'biomarker', 'biomarker testing', and 'clinical utility' to establish what services are covered under the program.

REQUIREMENT

Agency for Health Care Administration required to establish provider reimbursement schedules and billing codes for biomarker testing services.

Medicaid managed care plans required to cover certain colorectal cancer tests at specified levels.

Removed requirements for individual, group, and HMO health insurance plans to provide colorectal cancer screening coverage without cost-sharing.

TIMELINE

Deadline set for August 1, 2025 for the agency to establish provider reimbursement schedules and billing codes.

Floor votes · House Apr 8, 2025

How they voted

24–0

Passed · 5 other

Total votes 29

Apr 8, 2025

D Democratic7

6 Yea 1

85% Yea

R Republican22

18 Yea 4

81% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 8, 2025

House · Passed

House Vote: pass (24-0-5)

house

Apr 8, 2025

Lower · Passed

Now in Health & Human Services Committee

lower

Apr 8, 2025

Lower · Passed

Reported out of Budget Committee

lower

Apr 8, 2025

Lower · Passed

Favorable by Budget Committee

lower

Apr 4, 2025

Lower · Passed

Added to Budget Committee agenda

lower

Mar 31, 2025

Lower · Passed

Now in Budget Committee

lower

Mar 31, 2025

Committee

Referred to Health & Human Services Committee

lower

Mar 31, 2025

Committee

Referred to Budget Committee

lower

Mar 28, 2025

Lower · Passed

Reported out of Health Care Facilities & Systems Subcommittee

lower

Mar 27, 2025

Lower · Passed

Favorable with CS by Health Care Facilities & Systems Subcommittee

lower

Mar 25, 2025

Lower · Passed

PCS added to Health Care Facilities & Systems Subcommittee agenda

lower

Mar 5, 2025

Lower · Passed

Now in Health Care Facilities & Systems Subcommittee

lower

Mar 5, 2025

Committee

Referred to Health & Human Services Committee

lower

Mar 5, 2025

Committee

Referred to Budget Committee

lower

Mar 5, 2025

Committee

Referred to Health Care Facilities & Systems Subcommittee

lower

2 primary · 0 co-sponsors